Status:
COMPLETED
Use of Computer-based Patient-reported Data to Assess Long Term and Late Effects of Head and Neck Cancer at the Point-of-care
Lead Sponsor:
Danish Cancer Society
Collaborating Sponsors:
The Ministry of Science, Technology and Innovation, Denmark
Sygekassernes Helsefond
Conditions:
Head and Neck Cancer Patients
Late Effects
Eligibility:
All Genders
Phase:
NA
Brief Summary
Patient-reported information on outcomes such as symptom-burden and health-related quality of life (QoL) is regarded as a useful tool to improve quality of care in clinical cancer research. However, i...
Eligibility Criteria
Inclusion
- Prevalent recurrence free patients with cancers in the tongue, oral cavity, pharynx and larynx attending the oncology clinic at Herlev Hospital, Herlev, Denmark. 9 months to 5 years after end of treatment
Exclusion
- Patients with recurrence of their cancers and patients still in treatment.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2014
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01803061
Start Date
September 1 2010
End Date
July 1 2014
Last Update
March 6 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev Hospital
Herlev, Denmark, 2730
2
Danish Cancer Society Research Center, Unit of Suvivorship
Copenhagen, Ø, Denmark, DK-2100